Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) EBT (2016 - 2025)

Historic EBT for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $87.8 million.

  • Pediatrix Medical's EBT rose 24784.23% to $87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.2 million, marking a year-over-year increase of 17464.38%. This contributed to the annual value of -$101.3 million for FY2024, which is 10955.98% down from last year.
  • Pediatrix Medical's EBT amounted to $87.8 million in Q3 2025, which was up 24784.23% from $55.0 million recorded in Q2 2025.
  • Pediatrix Medical's 5-year EBT high stood at $87.8 million for Q3 2025, and its period low was -$167.7 million during Q2 2024.
  • In the last 5 years, Pediatrix Medical's EBT had a median value of $30.8 million in 2023 and averaged $12.5 million.
  • In the last 5 years, Pediatrix Medical's EBT surged by 97910.56% in 2021 and then plummeted by 738688.95% in 2022.
  • Over the past 5 years, Pediatrix Medical's EBT (Quarter) stood at $53.5 million in 2021, then crashed by 48.01% to $27.8 million in 2022, then tumbled by 599.03% to -$138.8 million in 2023, then surged by 124.0% to $33.3 million in 2024, then surged by 163.38% to $87.8 million in 2025.
  • Its EBT stands at $87.8 million for Q3 2025, versus $55.0 million for Q2 2025 and $28.1 million for Q1 2025.